Children and staff members at the Mount Cotton State School, an elementary school near a rainforest in Queensland, Australia, have spotted wallabies, koalas and snakes over the years.
But recently, builders who were adding new classrooms to the school made a discovery that stood out even among the famously diverse fauna of Australia, a continent where spiny mammals lay eggs, flightless birds kick with daggerlike claws and platypuses glow in the dark. The builders found a giant wood moth, which can have a wingspan of up to nine inches.
The moth — fuzzy-looking and mottled gray, with a passing resemblance to a well-loved stuffed animal — was found on the side of the new building.
“It was an amazing find,” said Meagan Steward, the school principal, in an interview with ABC Radio Brisbane that was broadcast on Sunday. “This moth was something that we had not seen before.”
white witch moth, which is found in Mexico and South America, does, with a wingspan of up to 12 inches.
The giant wood moth’s large thorax — about the width of a finger — is what helps make it the heaviest moth, Dr. Shockley said. A female can carry up to 20,000 eggs in her abdomen.
Dr. Shockley said he was fascinated by the animal because it spends a majority of its life as an “immature” rather than as an adult, in contrast to humans and other animals; he said he was also impressed by the status of larval wood moths as a source of food for some Indigenous Australians.
“You can eat them raw or you can cook them,” Dr. Shockley said. “The flavor has basically been said to be something like almonds.”
The discovery of the moth at the school could help entomologists gather more data about the species’ distribution, which remains something of a mystery, he said.
“I think any entomologist would be really excited by finding these things,” Dr. Shockley said. “I’m a beetle person, and this would still be superexciting to me.”
When you stand in the Chimanimani Mountains, it’s difficult to reconcile their present serenity with their beleaguered past. From the valleys below, enormous walls of gray stone rise above dense deciduous forests. Hidden among various crevices are ancient rock paintings, made in the late Stone Age by the San people, also known as Bushmen; they depict dancing men and women, and hunting parties chasing after elephants. There’s even a painting of a crocodile so enormous that it may forever deter you from the riverbank.
As you climb higher, toward Mount Binga, Mozambique’s highest peak, the forests flatten into expanses of montane grasslands. Wild, isolated, lost in time, it’s a place where rich local traditions live on, where people still talk about ancestral spirits and sacred rituals. A local guide there once told me about a sacred mountain, Nhamabombe, where rainmakers still go to make rain.
Gorongosa, Mozambique’s most famous national park, Chimanimani National Park marks the latest triumph in an environmental renaissance for a country where, just 30 years ago, armies were still funding wars with the blood of poached wildlife.
BIOFUND, a nonprofit dedicated to conservation, and Fauna & Flora International, an international wildlife conservation organization. The expeditions involved scientists from seven countries, including several from Mozambique.
As a doctoral student completing my field research in Gorongosa, I participated as the mammal expert on the annual biodiversity surveys. After finishing my Ph.D. in 2018, I shifted to a career in photojournalism. I went on my last two biodiversity surveys in 2018 and 2019 — first in Chimanimani’s buffer zone, then in the heart of Chimanimani — as the photographer.
These surveys are like biological treasure hunts. Scientists, each with a different specialty, are let loose in the landscape to unearth as many species as they can.
The mammalogists set camera traps for large mammals like antelope, live traps for small mammals like rodents, and mist nets for bats. The ornithologists arm themselves primarily with binoculars, their ears and an astonishing memory for bird songs. By day, the entomologists sweep their butterfly nets in the grassland and, by night, often stand at a light surrounded by clouds of insects, picking them out of their hair and waiting for something interesting to land.
The herpetologists, or reptile and amphibian specialists, shoot rubber bands to temporarily stun lizards, dive into knee-high water after agile frogs, and generally avoid being bitten by venomous snakes while far away from medical care.
By contrast, the botanists have a tranquil task: there’s something relaxing and almost elegant about strolling across the mountainside, inspecting beautiful flowers and pressing some in paper for posterity.
Biodiversity surveys are not for the faint of heart, and they cast more than a little doubt on the idea that scientists are all boring nerds in lab coats.
Through the years, I myself have been bitten by a tarantula, several bats, a mouse, countless insects and even a (nonvenomous) snake. Once, back in New Jersey after a survey, a doctor flushed my ears when I complained of muffled hearing. Out poured dozens of tiny, wax-entombed insects in various shapes and sizes. (The experts often wear plugs in their ears while standing at the insect light for this exact reason.)
There’s something about this change of pace that I’ve always found immensely appealing. In the cool Chimanimani mornings, the scientists who didn’t have to be up before dawn chasing their species would lounge, sipping instant coffee from plastic mugs and watching the clouds cast shadows onto the giant rock dome.
Featuring a diverse set of rare and endemic avian species, Chimanimani is a bird-watcher’s paradise. At Rio Nyahedzi, a camp some 4,000 feet above sea level, the survey’s ornithologists found the bokmakierie, a bird that was last seen in Mozambique in the 1970s. (Nyahedzi is close to Mount Binga, which lies directly on the border between Mozambique and Zimbabwe.)
As the park gets more attention, it will also attract hikers and rock climbers. Some of the park’s most beautiful waterfalls are 15 miles from the nearest road, and you can hike for days without seeing another human being. The park vibrates with solitude, adventure and discovery.
At the end of the two surveys, scientists in Chimanimani had found more than 1,400 species: 475 plants, 43 mammals, 260 birds, 67 amphibians and reptiles, and at least 582 species of insects. Some are new to science.
“It was amazingly productive as a rapid survey,” said Rob Harris, of Fauna & Flora International’s Mozambique program, emphasizing that the discoveries took place in a relatively short period of time.
The incredible diversity uncovered by the surveys is only a part of what’s known. As a whole, the Chimanimani Mountains are known to contain almost 1,000 plant species alone. Seventy-six plant and animal species are endemic to the Chimanimani Mountains, meaning they exist nowhere else on Earth.
Like all wild places, Chimanimani’s future is anything but certain. Endemic species are particularly threatened by climate change; because of their restricted range, they don’t have anywhere else to go as conditions become unsuitable. And human population growth will continue to jeopardize the fringes of the park. “The deforestation outside the park and in the buffer zone was alarming,” said Zak Pohlen, an ornithologist.
But as I reflect on these surveys and my time in Mozambique, I can’t help but feel full of hope. I am inspired every day by the passion of young Mozambican conservationists to safeguard their country’s disappearing wilderness. And most of all, I’m inspired by their optimism.
One of the goals of these surveys is to train young Mozambicans to take over leadership roles in conservation. Ana Gledis da Conceição, a Mozambican mammalogist, for example, spent several years assisting me in surveying mammals; by 2019, she was co-leading the mammal team with Mnqobi Mamba, a master’s student at the University of Eswatini.
Ms. da Conceição says she’s exactly where she’s supposed to be — a young scientist who fights for the conservation of biodiversity. “I want to invite young people like me to embrace this cause for the good of all of us,” she said.
“In spite of everything,” she added, “Mozambique has much to contribute to the future of conservation.”
Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination.
All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition.
Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.
“We are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement. “Right now, these adverse events appear to be extremely rare.”
On a media call later on Tuesday morning, Dr. Marks said that “on an individual basis, a provider and patient can make a determination whether or not to receive the vaccine” manufactured by Johnson & Johnson.
While the move was framed as a recommendation to health practitioners in the states, the federal government is expected to pause administration of the vaccine at all federally run vaccination sites. Federal officials expect that state health officials will take that as a strong signal to do the same. Within two hours of the announcement, Gov. Mike DeWine of Ohio, a Republican, advised all health providers in his state to temporarily stop giving Johnson & Johnson shots. In New York, the health commissioner, Dr. Howard Zucker, said the state would halt the use of the vaccine statewide while federal officials evaluate the safety risks. Appointments for Johnson & Johnson’s shot on Tuesday at state mass sites would be honored with Pfizer doses, Dr. Zucker said.
The authorities in New Jersey, Connecticut, Massachusetts, Maryland, Nebraska, Georgia, Indiana, Texas and Virginia also said that they would follow the call from federal health agencies.
Scientists with the F.D.A. and C.D.C. will jointly examine possible links between the vaccine and the disorder and determine whether the F.D.A. should continue to authorize use of the vaccine for all adults or limit the authorization.
In the media call, federal health officials tried to reassure recipients of Johnson & Johnson’s vaccine while at the same time describing symptoms that they should watch out if they received a shot within the past month.
Dr. Schuchat said that the risk of dangerous blood clots is “very low” for people who received the vaccine more than a month ago.
“For people who recently got the vaccine within the last couple of weeks, they should be aware, to look for any symptoms. If you receive the vaccine and develop severe headaches, abdominal pain, leg pain or shortness of breath, you should contact your health care provider and seek medical treatment,” she said. She emphasized that an emergency meeting of the C.D.C.’s outside advisory committee, which has been scheduled for Wednesday, to discuss how to handle the vaccine in the future is made up of independent experts.
Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration, said she expects the pause in distributing and administrating the vaccine will last for “a matter of days” while officials investigate the cases. Officials also stressed that no serious safety problems have emerged with either of the other two federally authorized vaccines, developed by Pfizer-BioNTech and Moderna.
The move could substantially complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy. Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That concern has driven up some resistance to all vaccines, even though the AstraZeneca version has not been authorized for emergency use in the United States.
The vast majority of the nation’s vaccine supply comes from two other manufacturers, Pfizer-BioNTech and Moderna, which together deliver more than 23 million doses a week of their two-shot vaccines. There have been no significant safety concerns about either of those vaccines.
But while shipments of the Johnson & Johnson vaccine have been much more limited, the Biden administration had still been counting on using hundreds of thousands of doses every week. In addition to requiring only a single dose, the vaccine is easier to ship and store than the other two, which must be stored at extremely low temperatures.
Jeffrey D. Zients, the White House Covid-19 response coordinator, said Tuesday the pause “will not have a significant impact” the Biden administration’s plans to deliver enough vaccine to be able to inoculate all 260 million adults in the United States by the end of May. With the Johnson & Johnson setback, federal officials expect there will only be enough to cover fewer than 230 million adults. But a certain percentage of the population is expected to refuse shots, so the supply may cover all the demand.
Mr. Zients said the administration will still “reach every adult who wants to be vaccinated” by the May 31 target.
Federal officials are concerned that doctors may not be trained to look for the rare disorder if recipients of the vaccine develop symptoms of it. The federal health agencies said Tuesday morning that “treatment of this specific type of blood clot is different from the treatment that might typically be administered” for blood clots.
“Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given,” the statement said.
In a news release, Johnson & Johnson said: “We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines. At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine.” Janssen is the name of Johnson & Johnson’s division that developed the vaccine.
In the United States alone, 300,000 to 600,000 people a year develop blood clots, according to C.D.C. data. But the particular blood clotting disorder that the vaccine recipients developed, known as cerebral venous sinus thrombosis, is extremely rare.
All of the women developed the condition within about two weeks of vaccination, and government experts are concerned that an immune system response triggered by the vaccine was the cause. Federal officials said there was broad agreement about the need to pause use of the vaccine while the cases are investigated.
The decision is a fresh blow to Johnson & Johnson. Late last month, the company discovered that workers at a Baltimore plant run by its subcontractor had accidentally contaminated a batch of vaccine, forcing the firm to throw out the equivalent of 13 million to 15 million doses. That plant was supposed to take over supply of the vaccine to the United States from Johnson & Johnson’s Dutch plants, which were certified by federal regulators earlier this year.
The Baltimore plant’s certification by the F.D.A. has now been delayed while inspectors investigate quality control issues, sharply reducing the supply of Johnson & Johnson vaccine. The sudden drop in available doses led to widespread complaints from governors and state health officials who had been expecting much bigger shipments of Johnson & Johnson’s vaccine this week than they got.
The authorities in Ohio, New York, New Jersey, Connecticut, Massachusetts, Maryland, Nebraska, Georgia, Indiana, Texas and Virginia said on Tuesday that they would follow the call from federal health agencies to pause the administration of Johnson & Johnson’s vaccine after six women in the United States developed a rare disorder involving blood clots within about two weeks of vaccination.
CVS, the nation’s largest retail pharmacy chain, also said that it would immediately stop its use of Johnson & Johnson vaccinations and was emailing customers whose appointments would be canceled. A spokesman said that CVS would reschedule appointments “as soon as possible.”
Gov. Mike DeWine of Ohio and the state’s chief health official said they were advising all state vaccine providers to temporarily halt use of the single-dose vaccine. New York’s health commissioner, Dr. Howard Zucker, said the state would stop using the Johnson & Johnson vaccine, while the Food and Drug Administration and the Centers for Disease Control and Prevention evaluate the safety risks.
Connecticut health officials said they told vaccine providers to delay planned appointments and give an alternative option if they had the supply.
The C.D.C.’s outside advisory committee has scheduled an emergency meeting for Wednesday.
Jeff Zients, the White House Covid coordinator, said on Tuesday that the pause will not have a significant impact on the country’s vaccination campaign, which has accelerated in recent weeks as a rise in new virus cases threatens a fourth possible surge. Many states have already opened vaccination eligibility to all adults and others plan to by next week.
“Over the last few weeks, we have made available more than 25 million doses of Pfizer and Moderna each week, and in fact this week we will make available 28 million doses of these vaccines. This is more than enough supply to continue the current pace of vaccinations of 3 million shots per day,” Mr. Zients said in a statement.
Even though the reaction to the Johnson & Johnson shot is rare, any questions about the safety of the shots could bolster vaccine hesitancy.
Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention. The six women who developed blood clots were between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition.
“Right now, these adverse events appear to be extremely rare,” Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement on Tuesday. “People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.”
Like many states, New York had already prepared for a significant drop in its supply of the Johnson & Johnson vaccine after federal officials said that supplies would be limited because of a production issue at a Baltimore manufacturing plant. On Friday, Gov. Andrew M. Cuomo said that New York expected to receive 34,900 Johnson & Johnson shots, a decrease of 88 percent from the previous week.
Dr. Zucker, New York’s health commissioner, said that the state would honor appointments made at state-run mass vaccination sites for the Johnson & Johnson vaccine by giving people the Pfizer-BioNTech vaccine instead. That vaccine requires two doses, and it was not immediately clear how the state would handle the additional strain on its supply.
Mayor Bill de Blasio of New York City said that the city would work to reschedule appointments at city-run vaccine sites, giving those people the Pfizer or Moderna vaccines instead.
“Every site has been told this morning to stop giving the J&J shots,” he said at a news conference.
Mr. Cuomo received the Johnson & Johnson vaccine at a public appearance last month in Harlem, which he framed as an effort to boost confidence in that vaccine’s efficacy rate and to address vaccine hesitancy.
Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That vaccine has not been authorized for emergency use in the United States.
The virus is again surging in parts of the United States, but it’s a picture with dividing lines: ominous figures in the Northeast and Upper Midwest, but largely not in the South.
Experts are unsure what explains the split, which doesn’t correspond to vaccination levels. Some point to warmer weather in the Sun Belt, while others suspect that decreased testing is muddying the virus’s true footprint.
The contours of where the virus is resurgent can be drawn around one figure: states that are averaging about 15 new cases a day for every 100,000 people. The 23 states — including Alabama, Mississippi and Arkansas — that have averaged that or fewer over the past week seem to be keeping cases relatively low, according to a New York Times database. Nationally, the country is averaging 21 new cases per 100,000 people.
In the 27 states above that line, though, things have been trending for the worse. Michigan has the highest surge of all, reporting the most drastic increase in cases and hospitalizations in recent weeks. Illinois, Minnesota and others have also reported worrisome increases.
Nationally, reported cases in the United States are growing again after a steep fall from the post-holiday peak in January. In the past two weeks, new confirmed cases have jumped about 11 percent, even though vaccinations picked up considerably, with an average of 3.2 million doses given daily.
Some Southern states, like Alabama and Mississippi, are lagging in vaccinations. Only about 28 percent of people in each state have received at least one shot, according to a New York Times vaccine tracker. Still, case counts continue to drop in both states.
Health experts say cases are rising in the Northeast and Upper Midwest for several reasons, including pandemic fatigue, the reopening of schools and the resumption of youth sports.
Hospitalizations tend to follow the trend line in cases by a few weeks, and have been rising in some states, most notably in Michigan.
Officials are also concerned about the spread of more contagious virus variants, especially B.1.1.7, first identified in Britain. The variant is now the leading source of new coronavirus infections in the United States, the director of the Centers for Disease Control and Prevention said last week.
Just why those factors might affect some states more than others is hard to pinpoint, experts say.
Dr. David Rubin, the director of PolicyLab at the Children’s Hospital of Philadelphia, said warmer weather in Southern states and California was probably playing a role, because it allows people to gather outdoors, with less risk of transmission.
New case reports have fallen by about 11 percent in Georgia over the past two weeks. And in Alabama, new cases are down roughly 29 percent, with a 17 percent decline in hospitalizations.
Some experts say, though, that reduced testing in some states could be obscuring the true picture. Testing in Alabama, for instance, has started to dip, but the share of tests that come back positive has remained high, at 11.1 percent, compared with a nationwide average of 5.1 percent, according to data compiled by Johns Hopkins University.
“People who are symptomatic and go to their provider are going to get a test,” said Dr. Michael Saag, the associate dean for global health at the University of Alabama at Birmingham, but “the desire for people to go get tested just because they want to know what their status is has dropped off dramatically.”
Still, Dr. Saag said, there is probably not a hidden spike in cases in Alabama right now, since hospitalizations in the state remain low.
— Madeleine Ngo
Millions of Muslims on Tuesday began celebrating a second Ramadan in the middle of the pandemic, although in many countries the first day of the holy month offered the promise of a Ramadan with fewer restrictions than last year.
Mosques across the Middle East and other parts of the world were closed for prayer last year, and lockdowns prevented festive gatherings with friends and family. In Jerusalem, for instance, the Old City was largely empty and the Aqsa Mosque compound was closed to the public, as coronavirus cases were surging.
But a large degree of normalcy was back on Tuesday: The Old City’s narrow alleys were crowded, sweet shops were preparing Ramadan desserts, clothing stores were open and the Aqsa compound was welcoming worshipers.
“Last year, I felt depressed and I didn’t know how long the pandemic would last,” said Riyad Deis, a co-owner of a spice and dried fruit shop in the Old City, while selling whole pieces of turmeric and Medjool dates to a customer. “Now, I’m relaxed, I have enough money to provide for my family and people are purchasing goods from my shop — it’s a totally different reality.”
The enthusiasm of some didn’t mean the Ramadan would go as normal. Across several countries in the Middle East, the authorities imposed limitations on customs and festivities, requiring that mosques enforce social distancing and telling worshipers to bring their own prayer rugs and to wear face masks.
In Dubai, Saudi Arabia and Egypt, taraweeh, the optional extra prayers that worshipers can observe at night, were capped at half an hour. No one will also be allowed to spend the night in a mosque, as is common during the last 10 days of Ramadan.
Mosques around the region were also prohibited from serving the fast-breaking meal of iftar or the predawn meal of suhoor. Though Muslims could still gather for those meals with friends and family, the authorities asked them to limit those gatherings this year.
In Jerusalem, Omar Kiswani, the director of Al Aqsa Mosque, said he was overjoyed that the compound was open to worshipers, but still urged caution.
“These are times of great happiness — we hope the blessed Aqsa Mosque will return to its pre-pandemic glory — but these are also times of caution because the virus is still out there,” Mr. Kiswani said.
In Egypt, government officials and prominent television hosts linked to the authorities warned Egyptians of a third wave of infections as Ramadan approached, hinting that another curfew or other lockdown restrictions could be imposed if cases rose.
“If you want the houses of God to remain open,” Nouh Elesawy, an official who oversees mosques at the Egyptian Ministry of Endowments, said earlier this month, “adhere to the precautionary procedures and regulations.”
The Ramadan restrictions may hit the hardest in poor neighborhoods, where residents depend on iftar banquets usually sponsored by wealthy individuals or organizations. For those people, feasting and Ramadan gifts are likely to be rarer, with tourism still at a trickle and many small businesses still suffering from the economic effects of the pandemic.
In Lebanon and Syria, the pandemic has worsened economic crisis that will likely squeeze people’s ability to enjoy the holy month, more than the governments’ limited restrictions aimed at curbing the spread of the coronavirus.
In Syria, where experts say the official infection and death numbers for Covid-19 are far below the reality, the government has few restrictions in place. Worshipers will even be allowed to stand in line inside of mosques to pray together after breaking their fast, the Syrian Ministry of Religious Affairs said.
In Lebanon, which emerged recently from a strict lockdown, shops and restaurants can operate regularly during the day but must offer only delivery service during a nighttime curfew from 9:30 p.m. to 5 a.m.
India said on Tuesday that it would fast-track the approval of vaccines in use in other countries, a move aimed at rapidly increasing the country’s vaccine supply as it battles what is currently the world’s biggest coronavirus outbreak.
The Indian government said that it would grant emergency authorization to any foreign-made vaccine that had been approved for use by regulators in the United States, the European Union, Britain or Japan, or by the World Health Organization. The move had been recommended by a panel of Indian scientists and eliminates a requirement for drug companies to conduct local clinical trials.
“The decision will facilitate quicker access to such foreign vaccines” and encourage imports of materials that would boost India’s vaccine manufacturing capacity, the government said in a statement.
Earlier on Tuesday, India’s top drug regulator granted emergency approval to Sputnik V, the Russian-made vaccine, adding a third vaccine to the country’s arsenal on the same day that health officials recorded 161,736 new coronavirus infections in 24 hours.
It was the seventh straight day that India has added more than 100,000 cases, according to a New York Times database. Only the United States has seen a faster rise in infections during the pandemic.
India has administered about 105 million domestically produced vaccine doses for a population of 1.3 billion, but it is widely believed that the country needs to scale up inoculations rapidly because other measures have failed to control the virus. Many states have reimposed partial lockdowns and weekend curfews. In the country’s financial hub, Mumbai, health officials are racing to erect field hospitals as facilities report shortages of oxygen, ventilators and coronavirus testing kits.
And there is the risk of a superspreading event with the gathering of millions of Hindu pilgrims for the annual Kumbh Mela festival on the banks of the Ganges River, where the authorities say they are powerless to enforce social distancing.
India’s outbreak is reverberating worldwide as its pharmaceutical industry — which was supposed to manufacture and export hundreds of millions of doses of the AstraZeneca vaccine — is keeping most supplies at home. The approval of the Sputnik vaccine, whose first doses are expected to be available for use in weeks, offers hope that India could speed up its inoculation drive.
But it is unclear at this stage whether India will be able to procure significant quantities of other vaccines, including the Pfizer, Moderna and Johnson & Johnson shots in use in the United States. Major Western nations have accumulated much of the global supply of those vaccines and manufacturers are struggling to meet the surging demand.
India will import millions of Sputnik doses from Russia and then begin manufacturing the vaccine domestically, officials said. More than 850 million doses will be made, with some intended for export, Kirill Dmitriev, chief executive of the Russian Direct Investment Fund, a sovereign wealth fund that has financed the vaccine’s development, said in an interview with India’s NDTV channel.
“India is a vaccine-manufacturing hub and our strategic partner for production of Sputnik V,” Mr. Dmitriev said.
India has more than 13.6 million confirmed coronavirus cases, the second most after the United States, and 171,058 deaths, the fourth highest toll.
In other news around the world:
Japan has begun vaccinating 36 million people over age 65, the first time shots have been made available to the public during the country’s slow vaccine rollout. Officials said that 1,139 people nationwide had received doses on Monday, and that doses to cover all Japanese above the age threshold would reach municipal health facilities by the end of June. Although Japan has weathered the pandemic better than most countries, the pace of its vaccination effort, which until now had only covered 1.1 million frontline medical workers, has sparked public criticism and raised questions about readiness for the Tokyo Summer Olympics in just over three months.
Scotland on Tuesday moved forward plans to loosen its coronavirus lockdown, a day after the British government eased many restrictions in England. New rules beginning Friday will permit Scots to meet outdoors in groups of up to six adults from six households. The current rules restrict travel and set the maximum group size at four, from two households. Restrictions on shops and outdoor service in pubs, now relaxed in England, are scheduled to remain in Scotland until April 26.
Austria’s health minister resigned on Tuesday, citing personal health problems that he said have been exacerbated by the grueling job of helping lead the country’s response to the pandemic. “It feels like it has not been 15 months, but 15 years,” the minister, Rudolf Anschober, said in a statement. Mr. Anschober, 60, was appointed in January last year, as a Green party minister in a Conservative-led coalition, and has been one of the main faces of Austria’s coronavirus response. “In the worst health crisis in decades, the republic needs a health minister who is 100 percent fit. That is not currently me,” he said.
France will suspend all flights to and from Brazil, because of growing worries about the virus variant spreading there. “We see that the situation is getting worse” in Brazil, Prime Minister Jean Castex told lawmakers. The country previously permitted essential travel from Brazil, subject to testing and isolation requirements.
The World Health Organization on Monday evening called on governments to suspend the sale of live wild mammals in food markets to help prevent the emergence of new diseases. “Traditional markets, where live animals are held, slaughtered and dressed, pose a particular risk for pathogen transmission to workers and customers alike,” the agency said in a statement. Animals are the source of more than 70 percent of emerging infectious diseases in humans, it said. Early in the pandemic, Chinese officials suggested that the coronavirus outbreak might have started at a market. But W.H.O. experts said in a report last year that the role of animal markets in the story of the pandemic was still unclear.
BERLIN — Chancellor Angela Merkel’s government moved a step closer on Tuesday to securing the right to force restrictions on areas where the coronavirus is spreading rapidly, overriding state leaders reluctant to take action.
Ms. Merkel and her ministers approved a legislative proposal that would make it easier for the national government to enforce lockdowns and other limits on movement in regions where infection levels pass a set threshold. At current levels, it could lock down more than half of the country.
Under Germany’s decentralized leadership structures, the 16 state leaders have been meeting regularly with the chancellor to agree on nationwide coronavirus response policies. But with different regions experiencing different rates of infection, some state leaders have been reluctant to enforce the agreed limitations, leading to confusion and frustration among many Germans.
“I believe this amendment is as important as it is an urgent decision about how to proceed in the coronavirus pandemic,” the chancellor told reporters after meeting with her ministers.
Parliament still has to debate and approve the proposal, which would take the form of an amendment to the Protection Against Infection Act, and that process is expected to begin this week.
“We are in a situation where an emergency mechanism is necessary,” Ralph Brinkhaus, the leader of the Christian Democratic Union in Parliament, told reporters, before a meeting of his party lawmakers to discuss the amendment.
Under the proposed amendment, the federal government could force stores and cultural institutions to close and enforce limits on the number of people allowed to meet up in any region where infections surpass 100 new cases per 100,000 residents over a period of seven days.
More controversially, the law would also allow Ms. Merkel’s government to order that schools and day care centers close if the number of new infections reaches more than 200 per 100,000 inhabitants. Schools fall under the jurisdiction of the states, and local leaders are reluctant to relinquish that control.
Germany has registered more than three million infections and more than 78,700 deaths from Covid-19 since the virus began moving through the country last spring. It recorded 10,810 new cases of infection on Tuesday, bringing the national rate of infection to more than 140 per 100,000.
The number of patients in intensive care is expected to hit a record this month, as the country struggles to vaccinate enough people to get ahead of the spread of the highly contagious B.1.1.7 variant.
Britain has now offered vaccinations to everyone in the country age 50 and older, the government announced late on Monday, and is extending its program to another age group, the latest sign that the national rollout is continuing at pace.
On Tuesday, the authorities opened vaccinations to anyone 45 or older, yet the announcement came with a small hiccup: The website for the country’s National Health Service crashed for a short time after the younger cohort was invited to book appointments online.
The new step in the country’s vaccine rollout comes as the authorities eased several restrictions in England on Monday after months of stringent lockdowns, with pubs and restaurants opened for drinks and dining outside, and nonessential shops once again opening their doors.
Prime Minister Boris Johnson called the moment a “hugely significant milestone” and in a statement thanked those involved with the vaccine rollout. Mr. Johnson said the country was on track to offer all adults a vaccination by the end of July. More than 32 million people across Britain have received their first dose of one of the vaccines, according to government data.
The government said it had also already offered vaccinations to every health or care worker, and to everyone with a high-risk medical condition.
England has also began rolling out the Moderna vaccine, which will be offered as an alternative alongside the Pfizer BioNTech vaccine for those under 30, instead of AstraZeneca’s, which has been the mainstay of Britain’s program so far.
There have been concerns about a possible link between the AstraZeneca vaccine and very rare blood clots, and last week British regulators said an alternative should be provided for younger people. Potential infection still poses much greater risks than any vaccine side effect for all those over 30, they said, and could do so for younger people if cases surged again.
“The Moderna rollout marks another milestone in the vaccination program,” Stephen Powis, the medical director of the National Health Service, said in a statement. “We now have a third jab in our armory.”
The vaccination program, he added, “is our hope at the end of a year like no other” as he encouraged people to book their appointments.
But despite the hopeful vaccine news and the return to public life, the country is still battling new cases of the virus, and a cluster in two London neighborhoods of a worrisome variant first discovered in South Africa has prompted mass testing. Health workers have gone door to door to urge residents to get tested, even if they are not showing symptoms, as dozens of cases have emerged. Similar measures were carried out elsewhere in the city earlier this month.
Studies have shown that the variant contains a mutation that diminishes the vaccines’ effectiveness against it. Dr. Susan Hopkins, the chief medical adviser for the country’s test and trace campaign, said the cluster of cases in parts of South London was “significant.”
“It’s really important people in the local area play their part in stopping any further spread within the local community,” she said in a statement.
More than a year after the coronavirus first swept through New York, the streets of Sunset Park in southern Brooklyn reflect the pandemic’s deep and unhealed wounds intertwined with signs of a neighborhood trying to edge back to life.
The sidewalks are filling with shoppers and vendors. More businesses are welcoming customers. But owners still struggle to pay rent and keep their enterprises afloat, while many workers laid off after the city locked down last year remain without jobs.
And while the rate of vaccination in New York has increased significantly, the coronavirus still percolates through this densely packed neighborhood. The ZIP code that includes Sunset Park had the highest rate of positive cases in Brooklyn in early April, nearly double the citywide rate. Some residents have expressed skepticism about the vaccines, spooked by false information circulated over TikTok and other social media.
Adding to the stress is a spate of hate crimes and violence against people of Asian descent in New York and around the country, fed in some cases by racist claims that Asian-Americans are responsible for spreading the virus.
About a third of the residents in Sunset Park have received at least one dose of the vaccine, roughly the same level as the city overall, according to the city health data. But local leaders say they want to push that number much higher.
Kuan Neng, 49, the Buddhist monk who founded Xi Fang Temple on Eighth Avenue, said that people had come to him in recent weeks to express concerns over vaccines.
“Why do I need to do that?” is a common refrain, according to Mr. Kuan, followed by: “I’m healthy now. The hard times are over, more or less.”
“Many people want to delay and see,” Mr. Kuan said, himself included.
ArcLight Cinemas, a beloved chain of movie theaters based in Los Angeles, including the Cinerama Dome in Hollywood, will permanently close all its locations, Pacific Theaters announced on Monday, after the pandemic decimated the cinema business.
ArcLight’s locations in and around Hollywood have played host to many a movie premiere, in addition to being favorite spots for moviegoers seeking out blockbusters and prestige titles. They are operated by Pacific Theaters, which also manages a handful of theaters under the Pacific name, and are owned by Decurion.
“After shutting our doors more than a year ago, today we must share the difficult and sad news that Pacific will not be reopening its ArcLight Cinemas and Pacific Theaters locations,” the company said in a statement.
“This was not the outcome anyone wanted,” it added, “but despite a huge effort that exhausted all potential options, the company does not have a viable way forward.”
Between the Pacific and ArcLight brands, the company owned 16 theaters and more than 300 screens.
The movie theater business has been hit particularly hard by the pandemic. But in recent weeks, the majority of the country’s largest theater chains, including AMC and Regal Cinemas, have reopened in anticipation of the slate of Hollywood films that have been put back on the calendar, many after repeated delays because of pandemic restrictions. A touch of optimism is even in the air as a result of the Warner Bros. movie “Godzilla vs. Kong,” which has generated some $70 million in box office receipts since opening over Easter weekend.
Still, the industry’s trade organization, the National Association of Theater Owners, has long warned that the punishing closures were most likely to affect smaller regional players like ArcLight and Pacific. In March, the Alamo Drafthouse Cinema chain, which operates about 40 locations across the country, announced that it had filed for Chapter 11 bankruptcy protection but would keep most of its locations operational while it restructured.
That does not seem to be the case for Pacific Theaters, which, according to two people with knowledge of the matter, fired its entire staff on Monday.
The reaction to ArcLight’s closing around Hollywood has been emotional, including an outpouring on Twitter.
Devastating. Too many losses to process. It’s just too much… At some point when I’m less upset, I’ll tell you guys a funny story about my first time meeting Quentin Tarantino in the lobby of Hollywood Arclight. https://t.co/cFypJxEk4L
— Lulu Wang (@thumbelulu) April 13, 2021
Three people infected with the coronavirus died at a hospital in Bucharest on Monday evening after the oxygen supply stopped functioning, according to the authorities, the latest incident involving oxygen failure, which in many countries has driven up the virus death toll.
It was also another fatal setback for Romania’s ageing and overwhelmed health care system, which has suffered two fires in Covid-19 wards in recent months, killing at least 15 people.
Ventilators shut down at a mobile intensive care unit set up at the Victor Babes hospital in Bucharest after oxygen pressure reached too high a level, the country’s health authorities said in a statement, depriving patients of a vital supply. In addition to the three patients who died, five others were evacuated and moved to other facilities in the city.
Romania has recorded its highest rate of Covid-19 patients in intensive care units since the pandemic began, and on Sunday Prime Minister Florin Citu said that there were just six intensive care beds available across Romania, out of nearly 1,600.
Intensive care units in Hungary and Poland have also been at risk of being overwhelmed, as much of Eastern Europe has struggled to cope with a third wave of infections across the continent. Some Hungarian hospitals have sought medical students and volunteers to assist in Covid-19 wards, giving training to those without previous medical experience.
The mobile unit struck by the oxygen problem on Monday had only been in operation since Saturday, and it has epitomized long-running concerns over the country’s fragile health care system. In January, five patients died and a further 102 were evacuated from a different hospital in Bucharest after a fire broke out. In November, 10 patients hospitalized with the coronavirus died after a fire broke out in a hospital in the northeastern city of Piatra Neamt.
Romania’s spending on health care is among the lowest in the European Union, with just over five percent of gross domestic product allocated toward it, compared with 10 percent on average among other countries of the bloc.
More than 25,000 people who tested positive for the virus have died in Romania, and the authorities have closed schools and kindergartens throughout April as part of an extended Easter holiday.
The authorities have so far administered more than 3.5 million vaccine doses, in a population of about 19 million.
— Kit Gillet
Studies have found that women in academia have published fewer papers, led fewer clinical trials and received less recognition for their expertise during the pandemic.
Add to that the emotional upheaval of the pandemic, the protests over structural racism, worry about children’s mental health and education, and the lack of time to think or work, and an already unsustainable situation becomes unbearable.
Michelle Cardel, an obesity researcher at the University of Florida, worries that this confluence of factors could push some women to leave the sciences.
“My big fear is that we are going to have a secondary epidemic of loss, particularly of early career women in STEM,” she said.
Female scientists were struggling even before the pandemic. It was not unusual for them to hear that women were not as smart as men, or that a woman who was successful must have received a handout along the way, said Daniela Witten, a biostatistician at the University of Washington in Seattle.
Women in academia often have little recourse when confronted with discrimination. Their institutions sometimes lack the human resources structures common in the business world.
Compounding the frustration are outdated notions about how to help women in science. But social media has allowed women to share some of those concerns and find allies to organize and call out injustice when they see it, said Jessica Hamerman, an immunologist at the Benaroya Research Institute in Seattle.
In November, for example, a study on female scientists was published in the influential journal Nature Communications suggesting that having female mentors would hinder the career of young scientists and recommending that young women seek out male help.
The response was intense and unforgiving: Nearly 7,600 scientists signed a petition calling on the journal to retract the paper — which it did on Dec. 21.
The study arrived at a time when many female scientists were already worried about the pandemic’s effect on their careers, and already on edge and angry with a system that offered them little support.
Alisa Stephens found working from home to be a series of wearying challenges. Dr. Stephens is a biostatistician at the University of Pennsylvania, and carving out the time and mental space for that work with two young children at home was impossible.
Things eased once the family could safely bring in a nanny, but there was still little time for the deep thought Dr. Stephens had relied on each morning for her work.
Over time, she has adjusted her expectations of herself. “Maybe I’m at 80 percent as opposed to 100 percent,” she said, “but I can get things done at 80 percent to some extent.”
STOREY COUNTY, Nev. — You can’t ride the wild mustangs at the Tahoe-Reno Industrial Center in Nevada, but you’re nearly guaranteed to see bands of them loping over sagebrush in a scene that feels straight out of the 1800s.
At least until the dust clears and Tesla’s 5.3-million-square-foot “Gigafactory” comes into focus.
Welcome to the Silver State, where Elon Musk, a cryptocurrency tycoon and a brothel owner are using a symbol of Americana as a social media recruiting tool.
The water cooler used to be the spot in the office to talk shop. Then came on-site cafes, fitness and yoga studios, rooftop gardens, fire pits and rock-climbing walls. “The overarching trend of the last five years has been the hotelification of the office,” said Lenny Beaudoin, an executive managing director at CBRE.
For employers, the newest amenities to wow workers are ideological, with environmental commitments topping the list, said Jason H. Somers, the president of Crest Real Estate, a Southern California real estate consultancy.
progress by corporate giants, but most efforts remain so opaque that it’s tough to spot greenwashing, the use of sustainability efforts to appear more attractive.
Embracing high environmental standards can be challenging and expensive. Some companies pay others to reduce emissions. Others plant trees, which can take years to grow and rely heavily on water and care.
Tesla used a $1.3 billion state tax break to build its $5 billion factory, tapping into a local work force still reeling from the Great Recession and ushering in a wave of Silicon Valley heavies. Switch, a technology infrastructure company, set up three data centers, then Google gobbled up 1,200 acres. Blockchains bought 67,000 acres for $170 million in 2018, becoming the park’s biggest tenant.
hoped to transform the expanse into an experimental city run by his encrypted digital systems. He pledged to build 15,000 homes, turning it into a huge innovation zone, with his company overseeing everything from schools to courts, law and water.
“I want this to become the greatest social experiment in the history of the world,” he said. “It’s going to be a cross between Disneyland and the chocolate factory from Willy Wonka.”
He’ll have to rethink the scope: In March, the county voted against the secession plan.
Mr. Berns says he plans to develop around 25,000 of his 67,000 acres, but for now, it will remain an outpost for wild horses.
Nevada is home to more than half of the country’s 95,000 wild horses and burros, descendants of animals brought to the continent by Spanish conquistadors in the 1500s. Managed by the federal Bureau of Land Management to the tune of about $100 million annually, wild horses live on protected and private land crisscrossed by freeways.
Wild Horse Connection, an advocacy group. “Horses in traffic, on the wrong side of fencing, vehicular, train accidents, sick or ill horses.”
Rescues triple once mares start foaling, said Ms. Vance, whose annual budget is about $100,000, including small donations from the office park and tenants. She says further expansion depletes open spaces and decreases grazing areas.
“Horses have migration patterns, and when a development comes in, it cuts that off and there’s more interactions with people,” she said.
One solution is humane horse fertility so the animals, which can spend up to 16 hours a day eating, don’t overpopulate and overgraze.
American Wild Horse Campaign, has worked with the office park since 2012, spending more than $200,000 on fertility control, water and feeding in the last three years.
“Development displaces wildlife,” she said. Water stations help, she said, as does an underground crossing built by Switch.
But the horses will not offset the park’s overall carbon footprint, said Simon Fischweicher, the North American head of corporations and supply chains at CDP. Tenants like Tesla, whose lithium-ion batteries are costly to mine and nearly impossible to recycle, require a lot of energy.
Switch is installing its own solar panels, and there are two green fuel plants on site, but distribution and data centers use large amounts of water for heating and cooling, and “supply chain emissions are on average 11.4 times higher than operational emissions,” Mr. Fischweicher said.
Others question the need to use the horses as a lure. Mr. Thompson says most of the roughly 25,000 workers at the office park are blue-collar Nevadans living within an hour commute. They’re here for jobs, not because of horses.
Growth for the industrial park means luring workers from out of state, expanding limited housing nearby and developing more land — all of which jeopardize the wildlife incentive.
“Quality of food, retail choices and housing are going to shape those decisions more than having wild horses nearby,” Mr. Beaudoin of CBRE said. “I would never bet against someone like Elon Musk, but there are other factors to attract workers.”
HONG KONG — The most popular reward for hiking to the top of Fu Shan, a hill near Hong Kong’s westernmost point, is a selfie backed by the setting sun, the gleaming new bridge across the Pearl River or a flight landing at the nearby airport.
But for those who look more closely, there is the chance of a rarer prize: a glimpse of Chinese white dolphins swimming among fishing boats and cargo ships in the milky jade water.
“It’s amazing that Hong Kong still has this kind of rare animal,” said Michelle Chan, as she watched from Fu Shan on a recent day.
On the water below, a half-dozen tourist boats from the nearby fishing village of Tai O surrounded a single white dolphin. People cheered as it breached.
a report by 15 conservation groups and regional universities, as pollution, marine traffic and large-scale land reclamation projects have made the environment increasingly hostile.
coronavirus pandemic, however, has spurred some hope that the dolphins could find respite. Regional travel restrictions led to the suspension of high-speed ferries that crossed the Pearl River Delta between Hong Kong and Macau, a few times each hour, curbing one key threat to the animals.
“All vessel traffic is an issue, but high-speed ferries are a particular issue,” said Laurence McCook, head of oceans conservation for the WWF-Hong Kong. “They move so fast there’s a risk of vessel strike, but they also just physically disturb the dolphins because the dolphins run away from them.”
With the ferry suspension, dolphins are getting a little peace in one of their most favored areas in the region.
“What we have documented fairly clearly is that dolphins are moving back out into the ferry zone,” Mr. McCook said. “That actually is their most prime habitat under current circumstances.”
Still, the increased visibility of the white dolphins in places like the waters off Fu Shan is most likely the result of them being freer to use parts of their preferred territory rather than a sign that their numbers are rebounding, researchers say.
established a marine park to compensate for the loss of habitat, but dolphins have been slow to return, most likely because work continues in the area on a new runway.
“Every time we have a project like the bridge,” Mr. Ho said, “they set up a marine park as some kind of compensation. But we think it’s too late.”
On one recent survey trip, the first dolphin the team identified was number WL79, which Mr. Ho quickly identified by the V-shaped notch near its tail, the result of getting tangled in a fishing line or net.
“If we identify individuals, we can follow their life history — where they like to hang around, whether they have calves,” he said. “This is important, because one of the worries is reproductive rate of dolphins is quite low. To keep the population healthy, we want to see calves. But that’s not happening in Hong Kong.”
Newborn dolphins are gray in color and gradually lighten as they get older, their darker parts becoming distinct spots. Some become completely unspotted. They stay with their mothers for three to four years, but sometimes as long as eight or nine years, and typically live into their 30s.
Soon after the team spots another adult, WL168, identified by a large scar on its back. This one has also been seen near Macau, another Chinese territory 15 miles to the southwest, an indication of how local populations are not bound by political boundaries.
The dolphins eat a variety of fish, including gray mullet and lion head fish, the same sort of food, notes Mr. Ho, that appears in markets around Hong Kong. The overfishing of such species adds to the threats to dolphins, as does pollution from various sources including agricultural and industrial waste, urban runoff, discharge from ships and marine plastics.
Researchers also worry that dolphin viewing boats further stress the mammals, particularly those that race out from Tai O for a 20-minute, $25 trip.
Conservations groups say they hope the benefits of the ferry suspension will encourage regional governments and ferry companies to reconsider routes across the Pearl River. By traveling somewhat farther south, they could bypass key areas of dolphin habitat along Lantau, Hong Kong’s largest island. Such a move would only add a few minutes to the trip, they say.
It would, of course, ease just one of the many threats the dolphins are facing.
“Rerouting the ferries is not a magic cure-all,” Mr. McCook said. “But we think that can help us catalyze other actions and demonstrate it’s not a fait accompli that we lose the dolphins.”
Life can change in an instant, as I experienced when I first laid my eyes on a tall and bizarrely striking bird known as the greater adjutant.
It was India in 2018, in the northeastern state of Assam. I’d ended up there partly because of absurd circumstances, which involved being filmed for a reality television pilot while navigating a motorized rickshaw through the Himalayas. After traversing some of the highest and most dangerous roads in the world, including the Tanglang La mountain pass, I ventured off to see a traditional selection of endangered animals: Asian elephants, greater one-horned rhinos, western hoolock gibbons.
While en route to Guwahati, Assam’s capital, I saw a 5-foot-tall bird towering near the roadside. I was so taken by its appearance that I asked the driver to pull over so I could have a better look. It had piercing blue eyes, an elongated electric-yellow neck, a wobbly, inflatable neck pouch, long legs that moved with a stiff military gait, and spindly black hairs atop its (mostly bald) prehistoric-looking head. Little did I know that this outlandish animal — also endangered, though not famously so — would change the course of my professional life.
ecologically important water storage basin threatened by pollution and encroachment.
cattle egrets, were the spectacular greater adjutants, who were circling and stiffly marching alongside the other foragers.
rare and endangered scavengers.
taxonomic bias, since humans generally favor attractive mammals with forward-facing eyes. “The more people who see hargilas as a bad omen, disease-carrier and pest,” Dr. Barman told me, “the more I am obsessed.”
towel-like textile — with transfixing speed and expertise.
Carla Rhodes is a wildlife conservation photographer who lives in the Catskills. You can follow her work on Instagram.
What animal is most likely to host the next deadly coronavirus?
With the Covid-19 pandemic fueling a sense of urgency, researchers are finding new ways to predict the answer to that question.
“We are thinking about the next one,” says Maya Wardeh of the University of Liverpool, one of the authors of a paper in the journal Nature Communications that found there are far more mammals that can be infected with multiple coronaviruses than previously known.
A number of countries around the world are involved in or fund programs to test wild animals that have been linked to past outbreaks or are considered high risk, such as bats and rodents. Samples are collected and sequenced to identify novel viruses including those with the potential to infect humans. There are also efforts under way, including one at Ohio State University, to test domestic, wild, zoo and livestock animals to see whether they can get SARS-CoV-2, the pathogen that causes Covid-19 infections.
The Covid-19 pandemic has sparked additional strategies to better quantify risks, make more precise predictions and then home in on which animals require closer surveillance.
The mouse embryos looked perfectly normal. All their organs were developing as expected, along with their limbs and circulatory and nervous systems. Their tiny hearts were beating at a normal 170 beats per minute.
But these embryos were not growing in a mother mouse. They were developed inside an artificial uterus, the first time such a feat has been accomplished, scientists reported on Wednesday.
The experiments, at the Weizmann Institute of Science in Israel, were meant to help scientists understand how mammals develop and how gene mutations, nutrients and environmental conditions may affect the fetus. But the work may one day raise profound questions about whether other animals, even humans, should or could be cultured outside a living womb.
In a study published in the journal Nature, Dr. Jacob Hanna described removing embryos from the uteruses of mice at five days of gestation and growing them for six more days in artificial wombs.
Two other papers published in Nature on Wednesday report on attempts that edge near creating early human embryos in this way. Of course, Dr. Meissner said, creation of human embryos is years away — if it is permitted at all. And for now, international regulations prohibit studying human embryos beyond 14 days of fertilization.
In the future, Dr. Tesar said, “it is not unreasonable that we might have the capacity to develop a human embryo from fertilization to birth entirely outside the uterus.”
Of course, even the suggestion of this science fiction scenario is bound to horrify many. But it is early days, with no assurance human fetuses could ever develop entirely outside the womb.
Even assuming they could, Dr. Tesar noted, “whether that is appropriate is a question for ethicists, regulators and society.”